[Washington, D.C. and Berlin, Germany / 18 May 2025] Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws by withholding clinical

[Washington, DC / Berlin Germany – 22 April 2025] In commemoration of Earth Day, the Association of Medical Device Reprocessors and its members released the results of its 2024 member survey. Among the key findings (all data for 2024): Members helped health systems save $451,183,153 through cost savings (reprocessed “single-use” medical devices (SUDs) cost 30

The “Opt-In” Provision of the EU MDR (Article 17): Undermines EU Law and the Single Market Deprives Hospitals of Sustainable Medical Device Options, and Exacerbates Shortages in the Healthcare Supply Chain The time has come to change it. Summary Health systems are under enormous pressure. Urgently needed amendments to Article 17 of the EU Medical

[Washington, DC / Berlin Germany – 16 October 2024] A record 11,967 hospitals and surgical centers saved nearly half a billion dollars and eliminated greenhouse gas emissions equivalent to 7.5 Olympic swimming pools filled with gasoline by opting for regulated, commercially reprocessed 'single-use' medical devices (SUDs) instead of virgin SUDs in 2023. The data comes

23 September 2024 Statement from AMDR: Separating the Facts from the Myths about FDA Regulated, Reprocessed LigaSures™ In September 2020, a Medtronic-funded study purporting to show soiled reprocessed LigaSure devices was published in the Journal Surgical Endoscopy. After an exhaustive, year-long independent review by the publisher, an important correction was added to the article, indicating